To include your compound in the COVID-19 Resource Center, submit it here.

Avastin bevacizumab regulatory update

CBER Director Karen Midthun indicated she will allow Genentech to present information about future studies

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE